Scilex Holding Company (SCLX)
SCLX Stock Price Chart
Explore Scilex Holding Company interactive price chart. Choose custom timeframes to analyze SCLX price movements and trends.
SCLX Company Profile
Discover essential business fundamentals and corporate details for Scilex Holding Company (SCLX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - General
IPO Date
5 Mar 2021
Employees
115.00
Website
https://www.scilexholding.comCEO
Jaisim Shah
Description
Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid management products for the treatment of acute and chronic pain. Its commercial product is ZTlido 1.8%, a prescription lidocaine topical product for the relief of neuropathic pain related with post-herpetic neuralgia, which is a form of post-shingles nerve pain. It also offers SP-102, a viscous gel formulation of corticosteroid for epidural injections that is in a Phase III clinical trial to treat lumbosacral radicular pain; SP-103, which is in Phase II clinical trail for the treatment of low back pain; and SP-104, a novel low-dose delayed-release naltrexone hydrochloride formulation that has completed Phase I clinical trial for the treatment of fibromyalgia. The company is headquartered in Palo Alto, California. Scilex Holding Company is a subsidiary of Sorrento Therapeutics, Inc.
SCLX Financial Timeline
Browse a chronological timeline of Scilex Holding Company corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Nov 2025
EPS estimate is -$0.41, while revenue estimate is $26.25M.
Earnings released on 13 Aug 2025
EPS came in at -$7.42 falling short of the estimated -$0.41 by -1.71K%, while revenue for the quarter reached $9.90M , missing expectations by -62.30%.
Earnings released on 14 May 2025
EPS came in at -$2.26 surpassing the estimated -$4.20 by +46.19%, while revenue for the quarter reached $5.00M , meeting expectations.
Stock split effective on 15 Apr 2025
Shares were split 1 : 35 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Mar 2025
EPS came in at -$0.25 falling short of the estimated -$0.10 by -150.00%, while revenue for the quarter reached $14.90M , missing expectations by -16.24%.
Earnings released on 17 Jan 2025
EPS came in at -$6.29 falling short of the estimated -$0.17 by -3.60K%, while revenue for the quarter reached $14.44M , missing expectations by -19.21%.
Earnings released on 13 Aug 2024
EPS came in at -$6.29 surpassing the estimated -$6.99 by +10.01%, while revenue for the quarter reached $16.37M , beating expectations by +1.25%.
Earnings released on 13 May 2024
EPS came in at -$9.09 falling short of the estimated -$4.20 by -116.43%, while revenue for the quarter reached $10.88M , meeting expectations.
Earnings released on 11 Mar 2024
EPS came in at -$8.74 falling short of the estimated -$7.34 by -19.07%, while revenue for the quarter reached $13.46M , beating expectations by +17.82%.
Earnings released on 14 Nov 2023
EPS came in at -$22.03 falling short of the estimated -$5.94 by -270.88%, while revenue for the quarter reached $10.12M , missing expectations by -10.99%.
Earnings released on 11 Aug 2023
EPS came in at -$5.59 , while revenue for the quarter reached $12.58M .
Earnings released on 12 May 2023
EPS came in at -$0.22 , while revenue for the quarter reached $10.58M .
Earnings released on 7 Mar 2023
EPS came in at -$4.66 , while revenue for the quarter reached $11.92M .
Earnings released on 30 Sept 2022
EPS came in at $5.65 , while revenue for the quarter reached $11.38M .
Earnings released on 30 Jun 2022
EPS came in at -$4.42 , while revenue for the quarter reached $7.93M .
Earnings released on 31 Mar 2022
EPS came in at -$2.27 , while revenue for the quarter reached $6.81M .
Earnings released on 31 Dec 2021
EPS came in at $0.26 , while revenue for the quarter reached $8.26M .
Earnings released on 30 Sept 2021
EPS came in at -$0.33 , while revenue for the quarter reached $8.32M .
Earnings released on 30 Jun 2021
EPS came in at -$4.51 , while revenue for the quarter reached $7.83M .
Earnings released on 31 Mar 2021
EPS came in at -$4.51 , while revenue for the quarter reached $7.83M .
Earnings released on 31 Dec 2020
EPS came in at -$2.95 , while revenue for the quarter reached $5.89M .
Earnings released on 30 Sept 2020
EPS came in at -$2.95 , while revenue for the quarter reached $5.89M .
SCLX Stock Performance
Access detailed SCLX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.